NO964330L - Farmasöytisk sammensetning for terapeutisk behandling av tardiv dyskinesi og anvendelse derav - Google Patents
Farmasöytisk sammensetning for terapeutisk behandling av tardiv dyskinesi og anvendelse deravInfo
- Publication number
- NO964330L NO964330L NO964330A NO964330A NO964330L NO 964330 L NO964330 L NO 964330L NO 964330 A NO964330 A NO 964330A NO 964330 A NO964330 A NO 964330A NO 964330 L NO964330 L NO 964330L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical composition
- therapeutic treatment
- tardive dyskinesia
- tardive
- dyskinesia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7714694 | 1994-04-15 | ||
PCT/JP1995/000736 WO1995028177A1 (fr) | 1994-04-15 | 1995-04-14 | Composition medicinale destinee a traiter la dyskinesie tardive et utilisation de ladite composition |
Publications (2)
Publication Number | Publication Date |
---|---|
NO964330D0 NO964330D0 (no) | 1996-10-11 |
NO964330L true NO964330L (no) | 1996-10-11 |
Family
ID=13625663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO964330A NO964330L (no) | 1994-04-15 | 1996-10-11 | Farmasöytisk sammensetning for terapeutisk behandling av tardiv dyskinesi og anvendelse derav |
Country Status (8)
Country | Link |
---|---|
US (1) | US5712282A (no) |
EP (1) | EP0755685A4 (no) |
JP (1) | JP3598116B2 (no) |
AU (1) | AU2224195A (no) |
CA (1) | CA2187086A1 (no) |
FI (1) | FI964113A0 (no) |
NO (1) | NO964330L (no) |
WO (1) | WO1995028177A1 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020099003A1 (en) | 1997-10-28 | 2002-07-25 | Wilson Leland F. | Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof |
US6268352B1 (en) * | 1998-09-02 | 2001-07-31 | The Regents Of The University Of California | Promoters of neural regeneration |
EP1218003A4 (en) | 1999-09-13 | 2004-02-11 | David M Swope | COMPOSITION AND METHOD FOR REDUCING NEUROLOGICAL SYMPTOMATOLOGY |
JP2004532809A (ja) * | 2000-11-02 | 2004-10-28 | リサーチ ファウンデーション オブ シティ ユニバーシティ オブ ニューヨーク | ホスホジエステラーゼ4型を阻害することによって、神経系の再生および修復を刺激するための方法 |
IL149106A0 (en) * | 2001-04-20 | 2002-11-10 | Pfizer Prod Inc | Therapeutic use of selective pde10 inhibitors |
CA2471147C (en) * | 2002-01-04 | 2010-08-10 | Henry Ford Health System | Nitric oxide donors for treatment of disease and injury |
CA2493854A1 (en) * | 2002-06-26 | 2004-01-08 | Kyowa Hakko Kogyo Co., Ltd. | Phosphodiesterase inhibitor |
US20080188480A1 (en) * | 2005-02-22 | 2008-08-07 | Cedars-Sinai Medical Center | Use of Sildenafil, Vardenafil and Other 5-Phosphodiesterase Inhibitors to Enhance Permeability of the Abnormal Blood-Brain Barrier |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59148748A (ja) * | 1983-02-10 | 1984-08-25 | Takeda Chem Ind Ltd | ノナペプチド |
NL195004C (nl) * | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
JP2578001B2 (ja) * | 1989-12-11 | 1997-02-05 | 明治製菓株式会社 | 抗痴呆薬 |
-
1995
- 1995-04-14 CA CA002187086A patent/CA2187086A1/en not_active Abandoned
- 1995-04-14 JP JP52686595A patent/JP3598116B2/ja not_active Expired - Lifetime
- 1995-04-14 EP EP95915324A patent/EP0755685A4/en not_active Withdrawn
- 1995-04-14 WO PCT/JP1995/000736 patent/WO1995028177A1/ja not_active Application Discontinuation
- 1995-04-14 AU AU22241/95A patent/AU2224195A/en not_active Abandoned
- 1995-04-14 US US08/727,654 patent/US5712282A/en not_active Expired - Lifetime
-
1996
- 1996-10-11 NO NO964330A patent/NO964330L/no not_active Application Discontinuation
- 1996-10-14 FI FI964113A patent/FI964113A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
AU2224195A (en) | 1995-11-10 |
CA2187086A1 (en) | 1995-10-26 |
FI964113A (fi) | 1996-10-14 |
FI964113A0 (fi) | 1996-10-14 |
NO964330D0 (no) | 1996-10-11 |
EP0755685A4 (en) | 2000-05-03 |
JP3598116B2 (ja) | 2004-12-08 |
US5712282A (en) | 1998-01-27 |
EP0755685A1 (en) | 1997-01-29 |
WO1995028177A1 (fr) | 1995-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO994778D0 (no) | FremgangsmÕter og sammensetninger for behandling av tarmbetennelse | |
BR9407799A (pt) | Composição de matéria método de tratamento e composição farmaceutica | |
NO972125D0 (no) | Hemmoroideblandinger og fremgangsmåte for anvendelse | |
PL312064A1 (en) | Soft gelatinous form of pharmaceutical dose | |
NO994014L (no) | Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer | |
FI941826A (fi) | Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi | |
FI953479A0 (fi) | 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö | |
NO943511D0 (no) | Farmasöytiske preparater og anvendelse derav | |
DE69505657T2 (de) | Fluorcarbonetherhybriden enthaltende physiologich akzeptabele emulsionen und verwendungsverfahren | |
DK0862431T3 (da) | Anvendelse af pædiatrisk farmaceutisk formulering omfattende amoxycillin og clavulanat | |
EE9800234A (et) | Ravimeetod ja farmatseutiline kompositsioon | |
HUP9902655A3 (en) | Pharmaceutical composition of hedgehog proteins and use thereof | |
NO971900D0 (no) | Blandinger og behandling av multippel sklerose | |
NO20002189D0 (no) | Anvendelse av makrolider for behandling av cancer og mukuladegenerasjon | |
DE69620691T2 (de) | Therapeutisches Mittel zur Behandlung der Hypercholesterinämie | |
NO964330D0 (no) | Farmasöytisk sammensetning for terapeutisk behandling av tardiv dyskinesi og anvendelse derav | |
PT932400E (pt) | Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica | |
NO952568D0 (no) | Behandling av cellulosemateriale og blandinger for anvendelse for dette | |
IL121329A (en) | Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides | |
DK0670721T3 (da) | Lægemiddel til behandling og forebyggelse af knogle- og ledsygdomme | |
NO953003D0 (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
NO962782D0 (no) | Farmasöytiske formuleringer omfattende polytiourea, og metode for anvendelse derav | |
NO20003881D0 (no) | Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber | |
NO944386D0 (no) | Fremstilling og anvendelse av tetrazolderivater | |
ITMI911930A0 (it) | Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |